MCOLN1 rs121908003: What Your Genotype Means
The rs121908003 variant is a specific genetic change in the MCOLN1 gene known as a splice-site mutation. It is primarily recognized as a carrier-status marker for mucolipidosis type IV, a rare autosomal recessive lysosomal storage disorder.
What each genotype means
Typical MCOLN1 genotype
This genotype represents the wild-type or reference sequence for this position in the MCOLN1 gene. Individuals with this genotype do not carry the specific c.406-2A>G pathogenic mutation associated with mucolipidosis type IV. This result does not rule out the presence of other, less common mutations in the MCOLN1 gene.
This is the most common genotype in all populations, including the Ashkenazi Jewish population.
Carrier of MCOLN1 mutation
This genotype indicates you are a carrier of the c.406-2A>G mutation, also known as IVS3-2A>G. Carriers are typically asymptomatic because mucolipidosis type IV is an autosomal recessive condition, meaning it generally requires two copies of a pathogenic mutation to manifest symptoms. If you are planning a family, you may wish to discuss carrier screening and reproductive options with a genetic counselor.
Carried by approximately 1 in 100 individuals of Ashkenazi Jewish ancestry.
Increased risk for mucolipidosis
This genotype indicates the presence of two copies of the c.406-2A>G mutation. This mutation is a known cause of mucolipidosis type IV, a lysosomal storage disorder characterized by developmental delays and vision impairment. Please consult with a medical geneticist or your primary healthcare provider to discuss these results and appropriate clinical follow-up.
This genotype is very rare in the general population.
Understanding the Variant and Its Location
The variant rs121908003, often referred to in clinical literature as c.406-2A>G or IVS3-2A>G, is located within the MCOLN1 gene. This gene is situated on chromosome 19. The specific change involves a single nucleotide substitution in intron 3, which is a non-coding region of the gene. Because this mutation occurs at a splice site—the boundary where the cell's machinery cuts and joins RNA segments—it disrupts the normal processing of the MCOLN1 genetic instructions. This disruption typically leads to the production of a nonfunctional protein or prevents the protein from being created entirely. In the context of genetic testing, identifying this variant is significant because it is one of the two most common mutations responsible for the majority of mucolipidosis type IV cases in individuals of Ashkenazi Jewish descent.
The Role of the MCOLN1 Gene
The MCOLN1 gene provides the essential instructions for producing a protein called mucolipin-1. This protein is a member of the transient receptor potential (TRP) cation channel family and is primarily located on the membranes of lysosomes and endosomes. These cellular compartments act as the recycling centers of the cell, breaking down and disposing of waste materials. Mucolipin-1 functions as a channel that regulates the movement of ions, such as calcium, iron, and sodium, across these membranes. When the MCOLN1 gene is mutated, the resulting lack of functional mucolipin-1 impairs the transport of lipids and proteins. This failure causes these substances to accumulate within the lysosomes, leading to the cellular dysfunction characteristic of lysosomal storage disorders. The clinical manifestations of this accumulation include developmental delays, vision loss, and other systemic health issues.
Research and Clinical Significance
Research into rs121908003 is grounded in its role as a pathogenic variant for mucolipidosis type IV. Because the condition is inherited in an autosomal recessive pattern, an individual must inherit two copies of a pathogenic MCOLN1 mutation—one from each parent—to be affected by the disorder. A person who carries only one copy of this variant is considered a carrier and is generally not expected to exhibit symptoms of the disease. Clinical evidence strongly associates this specific splice-site mutation with the Ashkenazi Jewish population, where it, along with a large deletion mutation, accounts for the vast majority of disease-causing alleles. While the evidence for its pathogenicity is well-established in clinical genetics, it is important to note that carrier screening is typically offered to individuals with specific ethnic backgrounds or family histories to help inform reproductive planning.
Population Frequency and Testing
The frequency of the rs121908003 variant varies significantly by ancestry. It is most frequently observed in individuals of Ashkenazi Jewish descent, where the carrier frequency has been estimated in various studies to be approximately 1 in 100 to 1 in 127. In the general population, the variant is much rarer. Because of this higher prevalence in specific groups, genetic counseling and carrier screening programs often include this variant as part of a standard panel for those of Ashkenazi Jewish ancestry. If you receive a result indicating you are a carrier, it simply means you have one copy of the mutation. It does not mean you have the disease. If you are concerned about your carrier status or reproductive risks, it is essential to consult with a certified genetic counselor or a medical professional who can interpret these results in the context of your personal and family health history.
How common is this variant?
The rs121908003 variant is most common in the Ashkenazi Jewish population, with a carrier frequency estimated at approximately 1 in 100 to 1 in 127.
Frequently asked questions
What does it mean to be a carrier of MCOLN1?
Being a carrier means you have one copy of a mutated MCOLN1 gene and one normal copy. Carriers typically do not show symptoms of mucolipidosis type IV because the condition is recessive.
Is this variant the only cause of mucolipidosis type IV?
No, there are at least 22 known mutations in the MCOLN1 gene that can cause the disorder. However, rs121908003 is one of the two most common mutations found in the Ashkenazi Jewish population.
Should I be tested for this variant?
Carrier screening is often recommended for individuals of Ashkenazi Jewish descent or those with a family history of mucolipidosis type IV. You should discuss the appropriateness of this test with a genetic counselor or your primary care physician.
What happens if both parents are carriers?
If both parents are carriers of a mutation in the same gene, there is a 25% chance with each pregnancy that the child will inherit both mutations and be affected by the disorder. Genetic counseling is recommended to understand these risks.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908003?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29